hotspot -WSS

hotspot

author：knowledge 2025-09-27 16:47:19 - browse：21353

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Readout LOUD podcast: A CRISPR milestone, biotech mixology

explore

WSS

World's first CRISPR

UPS workers' union leader explains what's at stake as strike edges closer

Morphosys mixed study results for blood cancer drug

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Ransomware attacks on hospitals: Study outlines patient impact

Wegovy, Zepbound and weight loss drugs that preserve muscle

focus

hotspot

entertainment

In Memoriam: Notable people who died in 2023

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Trump demands the U.S. pay no more for drugs than other countries … again

David Sabatini, ex

Alkermes shareholders re

Hospitals look to new technology to keep health care workers safe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Astellas still sees hope in its gene therapy after four deaths

State Dept. review finds Biden bears some blame for Afghanistan failures

CRISPR pioneers react to Casgevy, first gene

leisure time

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

North Korean leader's powerful sister says warplanes repelled US spy plane

World's first CRISPR

Hospitals look to new technology to keep health care workers safe

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

explore

knowledge

leisure time

focus